UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034696
Receipt number R000039553
Scientific Title Treatment outcome and long-term prognosis of antiviral therapy for chronic B or C infection-A multicenter cohort study
Date of disclosure of the study information 2018/10/30
Last modified on 2023/03/28 09:23:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment outcome and long-term prognosis of antiviral therapy for chronic B or C infection-A multicenter cohort study

Acronym

Treatment outcome of antiviral therapy for chronic B or C infection

Scientific Title

Treatment outcome and long-term prognosis of antiviral therapy for chronic B or C infection-A multicenter cohort study

Scientific Title:Acronym

Treatment outcome of antiviral therapy for chronic B or C infection

Region

Japan


Condition

Condition

Chronic hepatitis B or C

Classification by specialty

Hepato-biliary-pancreatic medicine Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Elucidate the virological effect and the development of hepatocellular carcinoma in the long-term after the antiviral therapy for patients with chronoic HBV or HCV infection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Virological effect and the development of hepatocellular carcinoma after the antiviral therapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) HBV: Patients with receiving nucleos(t)ide analogue treatment
(2) HCV: Patients with past history of DAA treatment

Key exclusion criteria

Any other clinical conditions that, in the opinion of the investigator, would make the subject unsuitable or unable to comply with any of the study procedures

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Eiichi
Middle name
Last name Ogawa

Organization

Kyushu University Hospital

Division name

Department of General Internal Medicine

Zip code

8128582

Address

3-1-1 Maidashi Higashi-ku, Fukuoka

TEL

092-642-5909

Email

e.ogawa.a65@m.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Eiichi
Middle name
Last name Ogawa

Organization

Kyushu University Hospital

Division name

Department of General Internal Medicine

Zip code

8128582

Address

3-1-1 Maidashi Higashi-ku, Fukuoka

TEL

092-642-5909

Homepage URL


Email

e.ogawa.a65@m.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University

Address

3-1-1 Maidashi Higashi-ku

Tel

0926425909

Email

e.ogawa.a65@m.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 04 Month 17 Day

Date of IRB

2017 Year 04 Month 17 Day

Anticipated trial start date

2017 Year 04 Month 17 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter obsevational cohort study


Management information

Registered date

2018 Year 10 Month 30 Day

Last modified on

2023 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039553


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name